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general practitioners to increase the
thoroughness of palliative care planning:
results of a pilot RCT with case vignettes
F. Weijers†, C. Veldhoven†, C. Verhagen, K. Vissers and Y. Engels*
Abstract
Background: In our aging society, palliative care should be a standard component of health care. However,
currently it is only provided to a small proportion of patients, mostly to those with cancer, and restricted to the
terminal phase. Many general practitioners (GPs) say that one of their most significant challenges is to assess the
right moment to start anticipatory palliative care. The “Surprise Question” (SQ1: “Would I be surprised if this patient
were to die in the next 12 months”?), if answered with “no”, is an easy tool to apply in identifying patients in need of
palliative care. However, this tool has a low specificity. Therefore, the aim of our pilot study was to determine if
adding a second, more specific “Surprise Question” (SQ2: “Would I be surprised if this patient is still alive after 12
months”?) in case SQ1 is answered in the negative, prompts GPs to plan for anticipatory palliative care.
Methods: By randomization, 28 GPs in the south-eastern part of the Netherlands were allocated to three different
groups. They all received a questionnaire with four vignettes, respectively representing patients with advanced organ
failure (A), end stage cancer (B), frailty (C), and recently diagnosed cancer (D). GPs in the first group did not receive
additional information, the second group received SQ1 after each vignette, and the third group received SQ1 and SQ2
after each vignette. We rated their answers based on essential components of palliative care (here called RADIANT score).
Results: GPs in group 3 gave higher RADIANT scores to those vignettes in which they would be surprised if the patients
were still alive after 12 months. In all groups, vignette B had the highest mean RADIANT score, followed by vignettes A
and C, and the lowest on vignette D. Seventy-one percent of GPs in groups 2 and 3 considered SQ1 a helpful tool, and
75% considered SQ2 helpful.
Conclusions: This innovative pilot study indicates that the majority of GPs think SQ2 is a helpful additional tool. The
combination of the two “Surprise Questions” encourages GPs to make more specific plans for anticipatory palliative care.
Keywords: Palliative care, Surprise question, Identifying tool, General practitioner, RADIANT
Background
Today most people in the Western world die of chronic,
degenerative illnesses and malignancies, rather than of acute
lethal diseases [1]. This implies that patients have a longer
deteriorating trajectory, with increased symptom burden. For
patients, carers, and family members, multidimensional
supportive or palliative care is needed, preferably starting
during disease-targeted care [1, 2]. The WHO defines pallia-
tive care as an early, multidimensional, proactive approach
to maintaining or retaining quality of life alongside accept-
ance of mortality and bereavement. However, a means of
demonstrating that a medical professional has fulfilled each
of these requirements is not currently available [3].
Temel et al. demonstrated that timely palliative care in
patients with metastatic non-small cell lung cancer alongside
standard treatment increased their quality of life, reduced
depressed mood, and even prolonged survival, as compared
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with standard treatment alone. Bakitas et al. showed that
early initiation of palliative care as compared to late initiation
led to an increase in life expectancy of cancer patients [4, 5].
Patients with other life-limiting diseases are also in need of
early palliative care and may benefit from it [6–8].
Most patients in an advanced stage of a life-limiting dis-
ease live at home in the Netherlands, where the general
practitioner (GP) acts as a gatekeeper and coordinator of
caregiving. This makes the GP the appropriate health care
professional to coordinate palliative care [9]. Unfortu-
nately, despite efforts to promote timely palliative care
planning and development of tools to identify patients
who might benefit from this approach, most GPs only
provide terminal, reactive care, mostly to patients with
cancer [10]. Consequently, in many patients in an
advanced stage of a life-limiting disease, anticipation of
future problems, needs, the patient’s wishes, and mortality
scenarios, does not occur in a timely fashion [3]. One of
the barriers to providing anticipatory palliative care is
identifying the right moment to start it, particularly in
patients with organ failure or frailty [11]. To assist GPs in
the identification of patients in need of anticipatory care
planning, several tools have been developed [12]. How-
ever, most tools contain many items and are time-
consuming to apply, when time is at a premium [13–15].
A way to assess the right moment to start palliative care
that costs little time is the “Surprise Question” (SQ):
“Would I be surprised if this patient were to die in the next
12 months?” [16] It appears to be sensitive for predicting 1-
year mortality [17–23]. However, it has a low specificity
and inadequate predictive value, which means that many
identified patients live longer than one year. Therefore, just
asking the SQ will identify a patient group that might be
too large for a GP to provide structured, anticipatory care
to. For that reason, there is a need for an easily applied tool
with a higher specificity. Hence, we suggested an additional
SQ that reads “Would I be surprised if this patient is still
alive after 12 months?” when SQ1 is answered in the
negative. Up to now, the value of the addition of this
second SQ in encouraging proactive palliative care has not
been explored, which makes this paper a unique contribu-
tion to the international literature.
We pilot tested whether adding SQ2 to SQ1 increases
the thoroughness of palliative care planning among GPs
and asked whether GPs think the double SQ is useful
and applicable in daily practice.
Methods
Study design and participants
Between April and July 2016, we invited a random sample
of 140 GPs in the south-eastern part of the Netherlands to
participate in our pilot vignette study. Because the second
SQ had never been studied before, we performed a pilot
RCT. We estimated that about 30% of invited GPs would
be willing to participate. Thus, by inviting 140 GPs to par-
ticipate, we would have about 10 participating GPs per
group. This number was expected to be sufficient to answer
the research questions, keeping in mind the explorative
character of this innovate study. In order to prevent socially
desirable answering, we told participating GPs that the pur-
pose of the study was to explore the influence of the type of
patient illness on GP’s care planning, without mentioning
that we were also interested in the influence of the SQs.
For the same reason, we did not mention that they would
be randomized. Forty-three GPs provided written informed
consent, and were randomized to one of the four arms,
after stratification for being a “specialized GP” (a GP who
has completed an extensive additional course in Palliative
care or in Elderly care). In each group, the GPs received a
questionnaire with four vignettes [Additional file 1]. Group
1 was used as a control group. Group 2 received only SQ1
after each vignette and in group 3 both SQs (SQ1 and SQ2)
were asked after each vignette.
Group 4 received an aid for anticipatory, multidimen-
sional care planning after each vignette in addition to both
SQs. However, this concerned another research question;
for that reason, in this paper we will only report the results
of groups 1–3.
Procedures
All participating GPs received the randomization-assigned
questionnaire online through Castor EDC (a valid research
database software program), or by mail, according to their
preference.
Each questionnaire contained four vignettes representing
four different patient cases. Vignette A portrays a patient at
an advanced stage of a chronic condition (chronic heart fail-
ure and chronic obstructive pulmonary disease), vignette B a
patient with terminal metastatic pancreatic cancer, vignette
C a frail lady with dementia and vignette D a relatively young
patient with a recently diagnosed metastatic colon carcin-
oma. These vignettes were inspired by real anonymized cases
from one of the authors (CV). [Additional file 1].
With each vignette, the respondent was asked if he would
plan any kind of care for this particular patient. If so, they
were asked to describe what instructions they would give to
their young and inexperienced GP-trainee (who therefore
needs explicit instructions) and about what kind of care
needs to be planned for this patient in the upcoming period.
At the end of the questionnaire, GPs in the corresponding
groups were asked their opinions about the applicability and
usefulness of, respectively, SQ1 and SQ2 [Table 1].
Outcome measures
All invited GPs were asked to provide socio-demographics
and palliative care experience-related data [Table 2]. All
information provided in the questionnaire was collected
anonymously in Castor EDC and blindly evaluated. As a
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scoring instrument did not exist to assess whether all re-
quirements of the WHO palliative care definition are ful-
filled, we created a scoring instrument in order to analyze
the open text fields and quantify them, dubbed the RAD-
boud Indicators of ANTicipatory care (RADIANT) score
[Table 3]. Therefore, we searched for guidelines from
Pallialine (a Dutch website with an evidence and consensus
based collection of palliative care guidelines, powered by the
Netherlands Comprehensive Cancer Organization; IKNL),
requirements from the WHO concerning Palliative Care and
information from thuisarts.nl (a Dutch website for patients,
powered by the Dutch College of General Practitioners, with
clear information about various subjects including treatment
limitations and end-of-life preferences) and a list of discus-
sion points about patients’ end of life, powered by the Royal
Dutch Medical Association [3, 24–26].
The primary outcome was the correlation between an-
swer combinations for SQ1 and SQ2 (“Yes/No I would /
would not be surprised if this patient were to die in the
next 12 months” and “Yes/No I would / would not be
surprised if this patient is still alive after 12 months”)
and RADIANT scores. If an answer combination of SQ1:
“No” and SQ2: “Yes” correlates with higher RADIANT
scores than answer combination of SQ1: “No” and SQ2:
“No”, it suggests that this answer combination prompts
GPs to plan anticipatory care more thoroughly.
Secondary outcomes were
a. differences in mean RADIANT scores per vignette A-D
between the three GP-groups, particularly between the
group with only SQ1 (group 2) and the group with both
SQs (group 3). This difference in scores represents the
extra value of the double SQ, as compared to SQ1 alone,
in prompting GPs to plan anticipatory palliative care and
the quality and thoroughness of care they described.
b. differences in mean RADIANT scores of all groups
together between the cases in vignettes A-D. (Do the
cases (type and progression of disease) influence the
time-point, kind, and extent of care planning?)
c. differences between study group 1–3 in how often
various aspects of the RADIANT score are mentioned in
care plans.
d. Finally, with open questions, we qualitatively explored
how GPs evaluated the single SQ and the double SQ.
Statistical analysis
Continuous, normally distributed data were expressed as
means and percentages. Because of the small numbers,
no effect sizes were calculated.
Table 1 Questions asked to the GPs regarding palliative care
provision
1. Which aspects trigger you in general to start palliative care?
(groups 1-3)* (2missing)
2. Do you think the Surprise Question, ‘Would you be surprised if
this patient were to die within 12 months? ‘ would be helpful to
identify patients in need of palliative care? (group 2)* (1 missing)
3. Is this Surprise Question applicable in daily practice? What are
your concerns /barriers to apply them? (group 2)* (1 missing)
4. Do you think the second Surprise Question, in addition to the
first SQ, would be of use in identifying patients in need of
palliative care? (group 3)* (1 missing)
5. Are these two Surprise Questions applicable in daily practice?
What are your concerns/barriers to apply them? (group 3) (1 missing)
*study group(s) that received this question
Table 2 Baseline characteristics
Characteristic Group 1 Group 2 Group 3 Non participantsa
N 9 10 9 42c
Age mean 48 45 53 59
Male gender n (%) 5 (56) 3 (30) 6 (67) 19 (45)
Type of practice n (%)
Single-handed practice 1 (11) 0 (0) 3 (33) 4 (10)
Two-man practice 3 (33) 6 (60) 2 (22) 12 (29)
Group practice 5 (56) 4 (40) 4 (44) 26 (62)
Years of working experience as GP, mean 16.7 14.5 22.5 20.5
GP trainer n (%) 2 (22) 6 (60) 6 (67) 15 (36)
Specialised GPb n (%) 0 (0) 1 (10) 0 (0) 1 (2)
Estimated number of palliative patients / year, mean 5.1 6.4 6.7 5.7
Interest in palliative care (0: not at all; 10 extremely interested), mean 7.9 8.3 7.9 8.0
Self-assessed expertise in palliative care (0: no expertise; 10 extremely high expertise), mean 6.7 7.1 7.7 7.3
aGPs who were invited to participate in the study, but did not give informed consent (97) or gave informed consent but did not complete the vignette
questionnaire (5)
bA GP that has followed an extensive additional course in palliative care or in elderly care
cGPs who provided socio-demographics and palliative care related data
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Ethical justification
The study was approved by the research ethics committee of
Radboud university medical center in accordance with the
Medical Research Involving Human Subjects Acts (WMO),
case number 2016–2716. We obtained written consent from
all participants to report individual anonymized data.
Results
Study participants
Of the 140 GPs approached, 57 did not want to participate
and 40 never answered our invitation; thus in total 97 GPs
did not provide informed consent [Fig. 1]. Fourty-three
GPs agreed to participate and were randomized into
groups 1–4 and sent the corresponding questionnaire. Of
those 33 were in groups 1–3. Twenty-eight GPs com-
pleted the questionnaire and 5 did not, mostly due to high
workload or personal circumstances [Fig. 1]. Of these 28
GPs, nine were in group 1, ten in group 2, nine in group
3. Their characteristics are included in Table 2.
Characteristics of participants in the different groups
were mostly similar. However, the percentage of males in
group 2 was lower and the percentage of GP-trainers in
group 1 was lower. The mean age was 49 (SD 9.2) and they
had an average GP work experience of 18 (SD 9.4) years.
Four GPs worked in an individual practice (14%), 11 GPs
(39%) in a two-man practice and 13 (46%) in a group prac-
tice. Only one of them (4%) completed an additional course
in palliative care or in elderly care and 14 (50%) were GP-
trainers. Participants treated a mean of six palliative pa-
tients a year, and GPs rated their interest in palliative care
as an 8.0 (scale 0–10; 0: not at all-10: extremely interested)
and their self-assessed expertise in palliative care as a 7.2
(scale 0–10; 0: no expertise-10: extremely high expertise).
Primary outcome measure: Correlation between answer
combinations on SQ1 and SQ2 and RADIANT scores
In group 3, GPs who answered that they would not be sur-
prised if this patient were to die in 12 months, and would
be surprised if this patient is still alive after 12 months, had
higher RADIANT scores than GPs in the same group who
answered that they would not be surprised if this patient
were to die in 12 months but they would also not be sur-
prised if this patient is still alive after 12 months [Table 4].
Table 3 RADIANT scoring table
Item Score Provenancea
1. Discusses patient’s personal aspects of quality of life 1 x, y
2. Discusses how to achieve patient’s personal goals 1 q, x, y
3. Adheres to the patient’s preferences 1 q, y
Provides attention to the following dimensions: q, x, y
4. Somatic problems
5. Social context and finances
6. Caregiving and activities of daily living
7. Existential and psychological issues
8. Involves other disciplines, including consultation team palliative care 1 y
9. Provides palliative care alongside disease-oriented care 1 x
Discusses advance care planning aspects:
10. Hospital admissions 1 q, z
11. Antibiotics use 1 q, z
12. CPR policy 1 q, y, z
13. Mechanical ventilation 1 q, z
14. Treatment limitations – not specified 1 q, y
15. Dying scenario’s 1 q, y
16. Life prolonging treatments (e.g. artificial feeding and i.v. fluids) 1 q, z
17. Preferences for end-of-life care (e.g. palliative sedation, euthanasia) 1 q, y, z
18. Preferred place of death 1 q, y, z
19. Writes assignment for the out-of-hours GP cooperative 1 q
20. Involves family and loved-ones in care planning 1 q, x, y
21. Provides care to family and loved-ones 1 x, y
Maximum score 21
aprovenance, q Royal Dutch Medical Association [26], x WHO definition of palliative care [3], y Pallialine [24], z Thuisarts [25]
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Secondary outcome measures
We did not find differences between GPs groups 1–3 in
Radiant scores. Regarding vignettes A, B and D, group 3
has lower scores than group 1 and 2 [Table 5]. In all
groups, vignette B (end-stage metastatic pancreatic can-
cer) had the highest mean score, followed by vignettes A
(advanced organ failure) and C (frailty), and the lowest on
vignette D (recently diagnosed metastatic colon carcin-
oma). In group 3, those vignettes of whom the GPs would
be surprised if they were still alive after one year had
mostly higher Radiant scores than the others. [Table 5].
GPs mentioned specific treatment limitations least often
in their care plans and in only three care plans (3%) GPs
mentioned that they would discuss how to achieve pa-
tients’ personal goals. There were no striking differences
between groups 1–3, except for involving other disciplines
(50% of the case vignettes in group 1, compared to 20%
for groups 2 and 3) and involving family and loved ones in
planning care (36% of the case vignettes in group 1, com-
pared to 22% and 25% in groups 2–3 respectively).
GPs’ opinion about triggers to start palliative care
Many GPs mentioned that, in general, the diagnosis of a
disease without curative options prompts them to start a
palliative care approach. Their intuition, or information
from a medical specialist, that death is approaching are
considered important triggers. They also mentioned that
they are prompted by frailty, complex situations, or when
a patient suddenly or gradually has increased care needs.
These latter situations give a GP the feeling of lagging be-
hind events and of no longer being able to act proactively:
“the feeling of being overtaken by events.” Also, the ab-
sence of a family caregiver or lack of a social network
prompts them to initiate palliative care. Some GPs espe-
cially want to adhere to the patient’s wishes and start pal-
liative care when the patient himself asks for it or gives
other signals of being open to a conversation about pallia-
tive care: “the tangibility of the finiteness of life and the
patient’s capacity to feel this too.” One GP in group 1 de-
scribed SQ1 as an important trigger, another GP in group
1 mentioned SQ2, although they were not offered these
questions and SQ2 has not been described before.
In the groups that received it, 12 out of 17 GPs who an-
swered SQ1 (71%) considered it a helpful tool. However,
GPs mentioned the inadequate specificity: “for anyone
over 85, this could be their last year, but I will not start a
palliative approach for all of them.” Regarding SQ2, 6 out
of 8 GPs who answered it (75%) considered it helpful.
Some of them already were familiar with SQ1 and found
it helpful to determine the right moment to start anticipa-
tory palliative care planning. One GP in group 3 noted: “I
use the first surprise question on a regular basis, but the
Fig. 1 Flowchart study participants. Legend: -
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second one is new to me. They seem to be the same, but
surely there is a nuanced difference. When the answer to
SQ1 is ‘No’ and to SQ2 is ‘Yes’, it is clearer to me that the
palliative phase has begun. The only objection is that these
questions are subjective and therefore a physician can
make a very inaccurate estimation. So I suggest answering
these two SQs over again when the situation changes.”
Discussion
Up to now, the classical SQ(1) alone was used and has
proven to have low specificity as a tool to predict death,
which may lead to a large and unselected group of pa-
tients for whom a GP should plan multidimensional,
proactive, palliative care. Some participating GPs in this
study underlined this shortcoming. Furthermore, its per-
formance is insufficient in non-cancer patients [23].
Adding SQ2 to SQ1 may improve specificity as prognos-
tic tool, but more meaningfully, combining the two SQs
will help a medical professional to select a smaller, more
accessible group of patients in need of anticipatory pal-
liative care. The GP can then focus on these patients
and plan palliative care more thoroughly.
Many tools have recently been developed to identify
patients in need of palliative care in general practice, e.g.
RADPACT, SPICT, NEPCAL, GSF [12]. These tools re-
quire more time investment and availability of indicators
and are therefore less suitable for screening of patients
in a GP’s daily practice. Also, most tools are focused on
Table 4 Answers on SQ1a and SQ2b and RADIANT scoresc per groupd and per vignette
Vignette Group 2e
n = 10
RADIANT score
group 2 mean
Group 3f
n = 9
RADIANT score
group 3 mean
Ag 10 SQ1 ‘no’ 6.0 5 SQ1 ‘no’ & SQ2 ‘yes’ 5.0
4 SQ1 ‘no’ & SQ2 ‘no’ 1.5
Bh 10 SQ1 ‘no’ 5.8 9 SQ1 ‘no’ & SQ2 ‘yes’ 5.0
Ci 9 SQ1 ‘no’ 4.0 5 SQ1 ‘no’ & SQ2 ‘yes’ 4.6
1 missing 3 SQ1 ‘no’ & SQ2 ‘no’ 4.0
1 missing
Dj 5 SQ1 ‘no’ 3.0 2 SQ1 ‘no’ & SQ2 ‘yes’ 3.0
4 SQ1 ‘yes’ 1.8 3 SQ1 ‘no’ & SQ2 ‘no’ 2.3
3 SQ1 ‘yes’ & SQ2 ‘no’ 0
1 missing
aSQ1: Would I be surprised if this patient were to die in the next 12 months?
bSQ2: Would I be surprised if this patient is still alive after 12 months?
cRADIANT score: see Table 3
d only group 2 and group 3 are represented here, as group 1 did not receive any SQ
egroup 2: received only SQ1 after each vignette
fgroup 3: received SQ1 and SQ2 after each vignette
gvignette A: advanced organ failure
hvignette B: end-stage metastatic pancreatic cancer
ivignette C: frailty
jvignette D: recently diagnosed metastatic colon cancer
Table 5 Mean cumulative RADIANT scoresa per group, per vignette and per SQ answer combination
Vignette Group 1
n = 9
Group 2
n=10b
Group 3
n=9b
Mean
n = 28
SQ1c all answers SQ1 ‘no’ SQ1 all answers SQ1 ‘no’ & SQ2d ‘yes’
Ae 4.6 6.0 6.0 3.4 5.0 4.7
Bf 5.9 5.8 5.8 5.0 5.0 5.6
Cg 4.6 4.0 4.0 4.4 4.6 4.3
Dh 2.9 2.7 3.0 1.6 3.0 2.4
Mean 4.5 4.6 4.7 3.6 4.4
aRADIANT score: see Table 3
bsome missing data: in both group 2 and group 3 one GP did not fill out vignettes C and D
cSQ1: Would I be surprised if this patient were to die in the next 12 months?
dSQ2: Would I be surprised if this patient is still alive after 12 months?
evignette A: advanced organ failure
fvignette B: end-stage metastatic pancreatic cancer
gvignette C: frailty
hvignette D: recently diagnosed metastatic colon cancer
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the palliative patient in the terminal phase, which im-
plies that after identification there will be less time for
proactive and anticipatory care planning. However, all of
these tools are useful for meeting patients’ wishes, needs,
and possible future scenarios and should be used in
combination during conversations with the patient.
We did not study the prognostic value of the SQs.
Already in 2005 Lynn suggested using the SQ to identify
“whether the person is in a fragile enough condition that
relatively minor worsening or intercurrent illnesses could
lead to mortality. Some of the patients identified by the sur-
prise question will end up living for years in a fragile state,
and some will die soon, but all typically need the services
that are priorities in the last phase of life: advance care
planning, comfort measures, assistance for daily activities,
family support, and so forth” [27]. Also Downar et al. noted
the importance of using the SQ as a screening test for pa-
tients who might benefit from a palliative care approach
[28]. Recognizing the patient in need is a prerequisite to
starting proactive palliative care [29], not the prognosis.
Most participating GPs considered the already-known
SQ1 and also the new SQ2 helpful.
As one of the triggers to start palliative care, some
GPs mentioned “if a patient himself asks for it”. How-
ever, De Vleminck et al. demonstrated that patients, and
particularly patients with disease trajectories other than
cancer, are very unlikely to start discussing anticipatory
care planning on their own initiative [30].
Strengths and limitations
This is the first study in which the SQ is used in com-
bination with case vignettes to see whether it prompts
GPs to thoroughly plan proactive palliative care, instead
of studying its prognostic value, which has been ques-
tioned before [31]. Adding a more specific trigger, SQ2,
is also innovative.
However, the study also has several limitations. In this
pilot study, the number of included GPs was limited and
not sufficient to discover statistical significance. It was
meant as a first exploration and therefore all results
should be interpreted with caution. Although we aimed to
use the results for a full-scale study, the relatively small
percentage of GPs that wanted to participate in this vi-
gnette study led us to abandon this plan. Instead, we have
started a prospective study in which GPs screened their
patient list with both SQs. One year later, a retrospective
medical record review will take place to determine sensi-
tivity and specificity of both SQs and whether the different
answers to these SQs are related to anticipatory care plan-
ning and care needs.
The response rate of 22% is about the same as in Schna-
kenberg et al.’s study (27.5%). In that study, GPs in
Germany and Sweden were sent surveys about palliative
care, which took no more than ten minutes to fill out [32].
Although we consider 22% fairly low, given the time re-
quired to complete the questionnaire (30–40 min) and
Dutch GPs’ high workload, it is satisfactory.
Vignette 4, concerning the patient with recently diag-
nosed metastatic colon carcinoma, was not completed by
two GPs and also had the lowest RADIANT score. We
think that mainly the case itself will have influenced the
score, but maybe the order in which the vignettes were
presented might have influenced this outcome as well.
Although the RADIANT score is not a validated tool,
it enabled us to quantify the open text fields and thus to
compare groups not only qualitatively but also quantita-
tively. We chose anticipatory care to have a high share
of the total RADIANT score, because we believe a med-
ical professional can only provide good palliative care
when, in addition to addressing actual problems, he also
anticipates possible future problems. Besides, a medical
professional can only be proactive when he is made
aware of his patient’s condition, which is what we aimed
to achieve with the SQs.
Whether the RADIANT score is related to the quality
of a palliative care plan (the obtained scores are a frac-
tion of the total possible score per vignette of 21 points)
still needs to be studied in real patient care, as well as
the validity and specificity of the tool.
Finally, we do not know whether all GPs in group 3
have understood the subtle but essential difference be-
tween SQ1 and SQ2. After all, we did not provide any
explanation about the intention or use of this new SQ2.
Recommendations
This simple, additional SQ2 was considered helpful by
GPs and showed promising pilot results. In four prospect-
ive studies in, respectively, general practice, a medical on-
cology outpatient clinic, the Intensive Care Unit and
nursing homes, we will further explore its usefulness and
validity.
Conclusions
In our pilot study, SQ2 in addition to SQ1 seems to con-
tribute to more extensive and anticipatory palliative care
planning for those patients of whom GPs would be sur-
prised if they were still alive after 12 months, and to less
extensive and anticipatory care planning when they
would not be surprised if a patient were still alive after
12 months. Most GPs who received it considered SQ2 a
useful addition to SQ1.
Additional file
Additional file 1: Case vignettes. Case vignettes. Case vignettes,
representing four different patient cases, inspired by real anonymized
cases of one of the authors CV. (PDF 193 kb)
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